Apr. 09, 2014News & Opinions
Sun Pharmaceutical Industries, India's largest drugmaker by market value, has agreed to buy compatriot generics manufacturer Ranbaxy Laboratories for $3.2 billion from Daiichi Sankyo, Japan's fourth-biggest pharmaceutical company
Apr. 08, 2014News & Opinions
Teva Pharmaceutical Industries, U.S. subsidiary of the Israeli generics drugmaker, has asked the U.S. Supreme Court to stop a lower court ruling from going into effect while the justices consider an appeal in a patent fight over Teva's ...
Apr. 07, 2014News & Opinions
Swedish generic drugmaker Meda has rejected a takeover approach by U.S. rival Mylan to create a combined company worth around $24 billion.
Apr. 05, 2014Topics
The Price of Doing Business - Following the 2012 implementation of the Generic Drug User Fee Act (GDUFA), an article in CHEManager Europe's July/August 2013 edition about GDUFA's Impact on the API Industry. The article summarized the ...
Apr. 01, 2014News & Opinions
Swiss drug maker Novartis has ended a late-stage clinical trial of a chronic heart failure drug early, following strong interim results.
The U.S. Supreme Court on Mar. 31 agreed to hear an appeal filed by Teva Pharmaceutical Industries in a patent fight over top-selling multiple sclerosis drug Copaxone.
Mar. 21, 2014News & Opinions
Novo Nordisk should still be able to introduce its long-acting insulin Tresiba on the U.S. market before rival products, despite being hit by a delay, the CEO of the Danish pharmaceutical company has said.
Mar. 03, 2014News & Opinions
Generic drugmakers are actively campaigning against a rule proposed by the U.S. Food and Drug Administration (FDA) that would require them to change the prescribing information on their products if they receive new safety information.
Feb. 21, 2014News & Opinions
Dublin, Ireland-based generic drugmaker Actavis is acquiring specialty pharmaceuticals company Forest Laboratories of New York in a cash and stock deal valued at about $25 billion.
Feb. 11, 2014News & Opinions
German generic drugmakers are annoyed at plans by the new Christian and Social Democrat coalition government to increase the mandatory rebate afforded the country's national healthcare companies because they say it discriminates against ...
The latest information directly via newsletter.